Developing anticancer drugs in orphan molecular entities - A paradigm under construction

Fabrice André

Résultats de recherche: Contribution à un journal › Editorial

16 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	763-765
Nombre de pages	3
journal	New England Journal of Medicine
Volume	378
Numéro de publication	8
Les DOIs	https://doi.org/10.1056/NEJMe1716821
état	Publié - 22 févr. 2018

Accès au document

@article{75f9436432f14c3abbebc87dda9c735b,

title = "Developing anticancer drugs in orphan molecular entities - A paradigm under construction",

author = "Fabrice Andr{\'e}",

year = "2018",

month = feb,

day = "22",

doi = "10.1056/NEJMe1716821",

language = "English",

volume = "378",

pages = "763--765",

journal = "New England Journal of Medicine",

issn = "0028-4793",

number = "8",

}

TY - JOUR

T1 - Developing anticancer drugs in orphan molecular entities - A paradigm under construction

AU - André, Fabrice

PY - 2018/2/22

Y1 - 2018/2/22

UR - http://www.scopus.com/inward/record.url?scp=85042463150&partnerID=8YFLogxK

U2 - 10.1056/NEJMe1716821

DO - 10.1056/NEJMe1716821

M3 - Editorial

C2 - 29466154

AN - SCOPUS:85042463150

SN - 0028-4793

VL - 378

SP - 763

EP - 765

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 8

ER -